Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 36 (1) , 21-31
- https://doi.org/10.2165/00003088-199936001-00003
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- How Well Do In Vitro Particle Size Measurements Predict Drug Delivery In Vivo?Journal of Aerosol Medicine, 1998
- Respiratory mucins: identification of core proteins and glycoformsBiochemical Journal, 1996
- Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lungJournal of Applied Physiology, 1995
- 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.1995
- Airway surface liquid thickness as a function of lung volume in small airways of the guinea pigJournal of Applied Physiology, 1994
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993
- Pressurised aerosol deposition in the human lung with and without an "open" spacer device.Thorax, 1989
- The Behavior and Significance of Slow‐Binding Enzyme InhibitorsPublished by Wiley ,1988
- THE SPECIFICITY OF VIRAL SIALIDASES - THE USE OF OLIGOSACCHARIDE SUBSTRATES TO PROBE ENZYMIC CHARACTERISTICS AND STRAIN-SPECIFIC DIFFERENCES1982
- A technique for the absolute measurement of activity using a gamma camera and computerPhysics in Medicine & Biology, 1979